Alessio Gerussi

16PUBLICATIONS
57CO-AUTHORS
Gastroenterology and hepatologyAutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Computational physiologyMedical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jan 09, 2026
Prospective, randomised, placebo-controlled, phase 2 clinical trial assessing the efficacy and safety of oral vancomycin in patients with primary sclerosing cholangitis with/out inflammatory bowel disease in Italy: study protocol of VanC-IT trial.

Laura Cristoferi, Daphne D'Amato, Cesare Maino

|Oct 09, 2025
Diagnosing Autoimmune Hepatitis: Histological Correlations and Emerging Technologies.

Giorgio Cazzaniga, Francesca Bolis, Chiara Caime

|Jan 11, 2025
Hepatotoxicity in Cancer Immunotherapy: Diagnosis, Management, and Future Perspectives.

Alberto Savino, Alberto Rossi, Stefano Fagiuoli

|Oct 27, 2022
LLM-PBC: Logic Learning Machine-Based Explainable Rules Accurately Stratify the Genetic Risk of Primary Biliary Cholangitis.

Alessio Gerussi, Damiano Verda, Claudio Cappadona

|Jun 24, 2022
The Role of Macrophages in Liver Fibrosis: New Therapeutic Opportunities.

Eleonora Binatti, Alessio Gerussi, Donatella Barisani

|May 14, 2022
The Role of Epigenetics in Primary Biliary Cholangitis.

Alessio Gerussi, Elvezia Maria Paraboschi, Claudio Cappadona

Pageof 3

Frequent Collaborators

12 joint publications

Pietro Invernizzi

6 joint publications

Laura Cristoferi

4 joint publications

Rosanna Asselta

3 joint publications

Marco Carbone